The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 7518 -7526
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0802230

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nagata, S.
Right arrow Articles by Pastan, I.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagata, S.
Right arrow Articles by Pastan, I.

Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T Cells1

Satoshi Nagata2,3,*,{dagger}, Tomoko Ise2,*,{dagger} and Ira Pastan*

* Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and {dagger} Cancer Biology Research Center, Sanford Research/USD, Sioux Falls, SD 57105

Fc receptor-like 3 (FCRL3) is a cell surface protein homologous to Fc receptors. The FCRL3 gene is present in humans but not in mice. We found that FCRL3 protein is expressed on 40% of human naturally occurring CD4+ regulatory T (nTreg) cells (CD4+CD25+CD127low). Sorted nTreg cells with the surface phenotype FCRL3+ and FCRL3 were both hypoproliferative to TCR stimulation and both suppressive on proliferation of conventional T cells (CD4+CD25) in vitro. They both expressed forkhead box p3 (Foxp3) protein, the intracellular regulatory T cell marker. However, in contrast to FCRL3 nTreg cells, FCRL3+ nTreg cells were not stimulated to proliferate by the addition of exogenous IL-2. In addition, Foxp3+ cells induced from conventional T cells by TGF-β treatment did not exhibit FCRL3 expression. These results suggest that the FCRL3+ subset of human nTreg cells identified in this study arise in vivo and Foxp3 expression alone is not sufficient to induce FCRL3 expression. FCRL3 may be involved in human-specific mechanisms to control the generation of nTreg cells.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.

2 S.N. and T.I. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Satoshi Nagata, Cancer Biology Research Center, Sanford Research/USD, 1400 West 22nd Street, Room L08, Sioux Falls, SD 57105. E-mail address: nagatas{at}sanfordhealth.org

4 Abbreviations used in this paper: FCRL, Fc receptor-like; Foxp3, forkhead box p3; GITR, glucocorticoid-induced TNFR family-related protein; nTreg, naturally occurring CD4+ regulatory T; Teff, T effector; Treg, regulatory T.

5 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.